A lead to explain the rare thromboses linked to the AstraZeneca vaccine

DECRYPTION – The dozens of cases recorded in Europe have given rise to a certain distrust of the vaccine developed by the Swedish-British laboratory and the University of Oxford. Seven deaths have still been announced by the British drug agency.

Three weeks ago, a wind of panic blew through Europe after the report of a series of cases of serious thrombosis (when a blood clot clogs a vein or an artery) which occurred in the days following the injection. AstraZeneca vaccine in relatively young subjects with no previous history. Many countries, including France, then temporarily suspended vaccination time to see more clearly. Quickly, however, it becomes fairly obvious that the risk, if it possibly exists, is extremely low and that the expected benefits of vaccination far outweigh.

However, that does not mean that the risk does not exist. On Saturday April 3, the British Medicines Agency (MHRA) announced that seven people who received the AstraZeneca vaccine have died of blood clots, out of a total of 30 cases identified so far. Among the dozens of cases of thrombosis identified, some are relatively atypical. By their location first: it is

This article is for subscribers only. You have 83% left to discover.

Subscribe: 1 € the first month

Can be canceled at any time

Already subscribed? Log in


Leave a Reply

Your email address will not be published. Required fields are marked *